Citi lowered the firm’s price target on Clorox (CLX) to $120 from $130 and keeps a Neutral rating on the shares. The firm views the company’s fiscal Q1 earnings as “soft” but “better-than-feared.” Clorox continues to have limited visibility, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: